Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma
Brian Ezekian(Duke University), Andrew S. Barbas(Duke Medical Center), Elisabeth T. Tracy(University of North Carolina at Chapel Hill), Harold J. Leraas(Duke Medical Center), Sarah Jane Commander(Duke Medical Center), Stuart J. Knechtle(Duke University), Paul M. Schroder(Duke Medical Center), Brian F. Gilmore(Duke University), Michael S. Mulvihill(Duke Medical Center), Susan G. Kreissman(Cancer Institute (WIA)), Brian C. Gulack(Duke University), Alisha Mavis(Duke University)
Cited by 39
Related Papers
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
|American Journal of Transplantation|2003|380
Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts
|New England Journal of Medicine|2013|366
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
|American Journal of Transplantation|2018|291